CityU biologists discover super-enhancers that switch on breast cancer genes

(City University of Hong Kong) Triple-negative breast cancer is an aggressive type of breast cancer with a high fatality rate. Currently, chemotherapy is the major treatment option, but the clinical result is unsatisfactory. A research team led by biologists at City University of Hong Kong (CityU) has identified and characterised a set of specific super-enhancers that stimulate the activity of the related critical cancer genes. The latest findings may help discover new effective drug targets for TNBC patients to improve their survival chance.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news